6-MAPB

6-MAPB
法律規範狀態
法律規範	加：Schedule I; 德：NpSG; 英：Class B;
識別資訊
	IUPAC命名法 1-(Benzofuran-6-yl)-N-methylpropan-2-amine; ;
CAS號	1354631-79-0
PubChem CID	122202866;
ChemSpider	32078890;
UNII	4J6PD2FN87;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID301010102 ;
化學資訊
化學式	C12H15NO
摩爾質量	189.26 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES CC(NC)CC1=CC(OC=C2)=C2C=C1;
	InChI InChI=1S/C12H15NO/c1-9(13-2)7-10-3-4-11-5-6-14-12(11)8-10/h3-6,8-9,13H,7H2,1-2H3; Key:QLAAURQYEAEHBO-UHFFFAOYSA-N;

6-MAPB（6-(N-甲基-2-氨丙基)苯並呋喃，英語：6-(N-methyl-2-aminopropyl)benzofuran）是一種含氮有機化合物，化學式C₁₂H₁₅NO，是6-APB與MDMA結構類似物，能作為精神藥物。^[1]^[2]^[3]^[4]

參考文獻

^ Welter J, Brandt SD, Kavanagh P, Meyer MR, Maurer HH. Metabolic fate, mass spectral fragmentation, detectability, and differentiation in urine of the benzofuran designer drugs 6-APB and 6-MAPB in comparison to their 5-isomers using GC-MS and LC-(HR)-MS(n) techniques (PDF). Analytical and Bioanalytical Chemistry. May 2015, 407 (12): 3457–3470 [2024-12-17]. PMID 25711990. S2CID 5475974. doi:10.1007/s00216-015-8552-2. （原始內容存檔 (PDF)於2024-12-19）.
^ Welter-Luedeke J, Maurer HH. New Psychoactive Substances: Chemistry, Pharmacology, Metabolism, and Detectability of Amphetamine Derivatives With Modified Ring Systems. Therapeutic Drug Monitoring. February 2016, 38 (1): 4–11. PMID 26327309. S2CID 20737913. doi:10.1097/FTD.0000000000000240.
^ Shimshoni JA, Winkler I, Golan E, Nutt D. Neurochemical binding profiles of novel indole and benzofuran MDMA analogues. Naunyn-Schmiedeberg's Archives of Pharmacology. January 2017, 390 (1): 15–24. PMID 27650729. S2CID 253741131. doi:10.1007/s00210-016-1297-4. hdl:10044/1/43622 .
^ Brandt SD, Walters HM, Partilla JS, Blough BE, Kavanagh PV, Baumann MH. The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats. Psychopharmacology. December 2020, 237 (12): 3703–3714. PMC 7686291 . PMID 32875347. doi:10.1007/s00213-020-05648-z.